Le Lézard
Classified in: Health
Subjects: RCL, PSF

Advisory - Unauthorized health product "Blow" may pose serious health risks


OTTAWA, Jan. 16, 2017 /CNW/ -

Issue
Health Canada is advising Canadians that it has seized the unauthorized health product "Blow," by Limitless Pharma, from Atomik Nutrition at 450 Boulevard de Mortagne, Boucherville, QC.

"Blow" is promoted as a pre-workout supplement and is labelled to contain the unauthorized drug 1,3?Dimethylamylamine (DMAA), which may pose serious health risks such as high blood pressure and stroke.

Who is affected

Affected product

What consumers should do

Background
1,3-Dimethylamylamine (DMAA) is a drug that is not authorized for use in Canada. Side effects include high blood pressure, shortness of breath, chest pain, stroke and psychiatric disorders.

What Health Canada is doing
Health Canada seized the product from the retail location after receiving a consumer complaint. Should additional retailers or distributors be identified, Health Canada will take appropriate action and inform Canadians.

For more information
Stay connected with Health Canada and receive the latest advisories and product recalls using social media tools.

To learn more about natural health products and other self-care products, visit Canada.ca/selfcare-products.

Également disponible en français

 

SOURCE Health Canada


These press releases may also interest you

at 14:20
The global gastroesophageal reflux disease (GERD) market  size is estimated to grow by USD 879.8 million from 2024-2028, according to Technavio. The market is estimated to grow at a CAGR of  3.2%  during the forecast period.  Rising geriatric...

at 12:48
Pendopharm, a division of Pharmascience Inc., announced today that it has signed an exclusive distribution agreement with Ascendis Pharma A/S ("Ascendis"), a global biopharmaceutical company headquartered in Copenhagen, Denmark. Under the terms of...

at 12:36
Imperial Tobacco Canada Limited ("ITCAN") has officially submitted its feedback to Health Canada regarding the proposed Ministerial Order on nicotine replacement therapy products (NRTs). ITCAN strongly believes that NRTs, especially innovative...

at 12:20
The "Regenerative Medicine Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Regenerative Medicine Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented...

at 12:10
The "Diagnostic Imaging Collaboration and Licensing Deals 2016-2024" report has been added to ResearchAndMarkets.com's offering. Diagnostic Imaging Collaboration and Licensing Deals provides a comprehensive understanding and unprecedented access to...

at 12:05
King Faisal Specialist Hospital & Research Centre (KFSH&RC) has achieved a significant milestone in its Robotic Cardiac Surgery Program, which was initiated in February 2019. Within its first year, the program performed 105 cardiac procedures. As of...



News published on and distributed by: